Status:
UNKNOWN
The ASOS-2 Trial Maternal Mortality Sub-study
Lead Sponsor:
University of Cape Town
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Conditions:
Maternal Mortality
Cesarean Section
Eligibility:
FEMALE
18+ years
Brief Summary
This sub-study is a mixed-methods analysis of a prospective case-series of maternal deaths within the African Surgical OutcomeS-2 trial cohort. The aims of the sub-study are i) to describe the context...
Detailed Description
This sub-study is a mixed-methods analysis of a prospective case-series of maternal deaths within the African Surgical OutcomeS-2 trial cohort. The aims of the sub-study are i) to describe the context...
Eligibility Criteria
Inclusion
- adult patients
- aged 18 years and over,
- admitted to participating hospitals
- undergoing elective and non-elective caesarean delivery
- who die following their operation before leaving hospital and within 30 days after the operation.
Exclusion
- prior participation in ASOS-2
- caesarean delivery at a hospital other than the study hospital (left censored)
- patients who are transferred to another hospital before death (right censored)
Key Trial Info
Start Date :
May 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04029207
Start Date
May 6 2019
End Date
July 31 2020
Last Update
January 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groote Schuur Hospital
Observatory, Western Cape, South Africa, 7925